143 related articles for article (PubMed ID: 25482019)
1. 4-hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington's disease.
Sandhir R; Mahajan N; Mehrotra A; Aggarwal A; Sunkaria A
Synapse; 2015 Mar; 69(3):128-38. PubMed ID: 25482019
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
Sandhir R; Sood A; Mehrotra A; Kamboj SS
Neurodegener Dis; 2012; 9(3):145-57. PubMed ID: 22327485
[TBL] [Abstract][Full Text] [Related]
3. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
Kumar P; Kumar A
J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
[TBL] [Abstract][Full Text] [Related]
4. Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease.
Sandhir R; Mehrotra A
Biochim Biophys Acta; 2013 Mar; 1832(3):421-30. PubMed ID: 23220257
[TBL] [Abstract][Full Text] [Related]
5. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
Hariharan A; Shetty S; Shirole T; Jagtap AG
Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
[TBL] [Abstract][Full Text] [Related]
6. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.
Sandhir R; Mehrotra A; Kamboj SS
Neurochem Int; 2010 Nov; 57(5):579-87. PubMed ID: 20643176
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
Mehrotra A; Sandhir R
Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits.
Mehrotra A; Kanwal A; Banerjee SK; Sandhir R
Neurobiol Aging; 2015 Jun; 36(6):2186-200. PubMed ID: 25976011
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
11. Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.
Sandhir R; Yadav A; Mehrotra A; Sunkaria A; Singh A; Sharma S
Neuromolecular Med; 2014 Mar; 16(1):106-18. PubMed ID: 24008671
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
Binawade Y; Jagtap A
J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
[TBL] [Abstract][Full Text] [Related]
14. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
Colle D; Santos DB; Moreira EL; Hartwig JM; dos Santos AA; Zimmermann LT; Hort MA; Farina M
PLoS One; 2013; 8(6):e67658. PubMed ID: 23799154
[TBL] [Abstract][Full Text] [Related]
15. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
Mehrotra A; Sood A; Sandhir R
Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats.
Kaur M; Prakash A; Kalia AN
Nutr Neurosci; 2016; 19(2):70-8. PubMed ID: 25896328
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism.
Kumar P; Kalonia H; Kumar A
Int J Toxicol; 2010; 29(3):318-25. PubMed ID: 20448265
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.
Gupta S; Sharma B
Eur J Pharmacol; 2014 Jun; 732():111-22. PubMed ID: 24690258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
